Plain-English translation of NCT07771127 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a heart catheterization procedure (a test or treatment where doctors access your heart through an artery in your groin), you need something to stop the bleeding at the puncture site. This trial is comparing a newer chitosan-based hemostatic pad to the traditional sandbag method. Researchers want to see which approach works better for controlling bleeding while also reducing pain, discomfort, and sleep problems.
The current standard treatment—placing a heavy sandbag on the puncture site for 4–6 hours while you lie flat—does stop the bleeding effectively, but it often causes pain, discomfort, difficulty urinating, and poor sleep. This trial is testing whether the newer pad can control bleeding just as well while letting you move around more and feel more comfortable during recovery.
You likely qualify if…
You likely don't qualify if…
You will undergo your scheduled heart catheterization procedure as planned. After the procedure, instead of the standard sandbag, you will receive either the new chitosan-based pad or a traditional sandbag to control bleeding at the puncture site. The research team will monitor you and ask you questions about pain, comfort, sleep quality, and any bleeding complications during your recovery. The study involves approximately 480 participants total across both treatment groups.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Turkey (Türkiye)